Lauren (Pflepsen) Frenz

Lauren (Pflepsen) Frenz has an extensive work experience in the pharmaceutical and healthcare industry. Lauren currently holds the position of Chief Business Officer at Vera Therapeutics, Inc. since April 2020. Prior to this role, they served as the SVP Corporate Strategy & Finance at Vera Therapeutics from August 2017 to April 2020.

Before joining Vera Therapeutics, Frenz worked at Gilead Sciences where they held various positions. Lauren was the Associate Director, HIV Marketing from April 2015 to July 2017. Prior to that, they served as the Associate Director, Commercial Planning & Operations from August 2014 to April 2015. Frenz started their tenure at Gilead Sciences as the Senior Manager, Commercial Planning & Operations from June 2012 to July 2014.

Frenz began their career at Leerink Partners LLC where they worked as an Associate, Strategic Advisory from August 2009 to July 2010. Lauren started at the company as an Analyst, Strategic Advisory from September 2007 to August 2009.

Overall, Frenz has gained valuable experience in various leadership and strategic roles in the pharmaceutical and healthcare industry throughout their career.

Lauren (Pflepsen) Frenz attended Princeton University, where they pursued a degree in Psychology and Neuroscience. Details regarding the start and end years for their undergraduate studies are not provided. Additionally, they went on to pursue a Master's in Business Administration (MBA) at Harvard Business School, studying there from 2010 to 2012.